ÂÜÀòÂÒÂ×

Dr. Pandey is a Distinguished Professor and Director of Pharmaceutical Chemistry, Department of Cell Stress Biology, at Roswell Park Cancer Institute. Dr. Pandey is an editorial board member on the Journal of Porphyrins and Phthalocyanines, Current Organic Chemistry, and Current Organic Synthesis. He is a founding member of the International Society of Porphyrins and Phthalocyanines. He has organized several national and international scientific symposiums and has delivered a large number of plenary and invited lectures all over the world on photodynamic therapy (PDT) and tumor imaging. He has received several awards including the Inventor of the Year Award (Niagara Frontier), the Rajiv Gandhi Award of Excellence, and ?Who's Who in Science.? He has been a reviewer of research grants for many international governmental agencies (US, UK, Canada, Singapore, France) and private foundations. He has 30 patents to his credit and published over 200 research papers in various reputable international journals, as well as many review articles and book chapters. His research is well funded by national funding agencies and private organizations. Dr. Pandey is also the founder of Photolitec, LLC, a biotech company to develop cancer imaging and therapeutic agents. Several of Dr. Pandey's developed agents have now moved into clinical trials in developing countries.